News
News
Sector News: Quell Therapeutics Raises $156 million in Oversubscribed Series B Financing to Advance its Pioneering Multi-Modular Engineered T Regulatory (Treg) Cell Therapy Pipeline and Platform
Quell Therapeutics Ltd (“Quell”), the world leader in the development of engineered T-regulatory (Treg) cell therapies for serious medical conditions ...
Read MoreNews
Press Release: FUJIFILM Diosynth Biotechnologies confirms £400 million investment plans to create the largest multi-modal biopharmaceutical manufacturing site in the United Kingdom
FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organisation (CDMO) for biologics, viral vaccines and viral vectors, has ...
Read MoreNews
News
News
Cell and gene therapy companies recruiting science manufacturing technician apprentices as part of the advanced therapies apprenticeship programme
Applications have opened for the second cohort of advanced therapies apprentices who will be Level 3 Science Manufacturing Technicians. 10 December 2018 This ...
Read More